Respiratory Infections News

There was plenty of FDA news this year not related to COVID-19.

Starting Jan. 5, the United States will require inbound air travelers from China to present a negative COVID-19 test or documentation of recovery from COVID-19 when boarding their flight, the CDC announced.

People with MS who are being treated with rituximab are strongly encouraged to receive mRNA SARS-CoV-2 vaccines and booster doses more than 6 months after their last rituximab infusion, researchers reported in JAMA Network Open.

An asymptomatic SARS-CoV-2 patient admission testing program can provide clinically relevant data, even during periods of lower transmission in which testing can be limited to patients who are not fully vaccinated, a recent study showed.

During the 2021-2022 influenza season, vaccination significantly reduced outpatient visits, consistent with prior seasons during which A(H3N2) viruses were predominant, especially among younger patients, recent study data showed.

As the COVID-19 pandemic enters its 4th year, its effect on children continues to be widely studied. We compiled a list of pediatric COVID-19 stories reported over the course of the past year.

We continue to be captivated by the stories you tell in our “Hooked on ID” series.

Protection against the omicron variant from the Pfizer-BioNTech COVID-19 vaccine waned after 3 months in children aged 5 to 11 years but was restored by a booster shot, according to study findings published in JAMA Network Open.

Community-acquired pneumonia (CAP) is associated with an estimated 1 million hospitalizations per year in the United States and is often treated with antibiotics.

COVID-19 placed a strain on infection prevention and control programs, highlighting vulnerabilities that existed before the pandemic, according to experts.